Solvin Develops Smart PVC Nanocomposite Material

Solvay announces today that its vinyls joint venture in Europe, SolVin, is launching NanoVin®, an innovative nanocomposite combining polyvinyl chloride (PVC) and nanoparticles of clay. This specialty product displays exceptional properties in terms of plasticity, viscosity and flow. These distinctive rheological properties make NanoVin® a so-called ‘smart material’, capable of sensing and reacting to changes in its environment (see Notes to the Editors below).

More specifically, NanoVin® is a ready-to-use product suitable for PVC paste applications, which require non-dripping and shear-thinning properties – meaning that the viscosity of the material decreases when a shear stress is applied to it and recovers a high value when the stress is released. These applications include for instance bodywork in the automotive industry as well as so-called thick coatings, such as artificial leather.

NanoVin® was developed at Solvay Research & Technology, the Group’s R&D campus in Neder-over-Heembeek (Belgium). The product is now entering into a pre-commercial phase, with a pilot production unit located in Jemeppe (Belgium).

“Research and innovation are feeding Solvay’s strategy of sustainable and profitable growth,” commented Michel Tchapian, Paste PVC Business Manager. “We succeeded in creating a smart material that opens up new commercial opportunities, thanks to our work on the combination of vinyl with nanoparticles of clay,” he said.

SolVin combines the competences of Solvay and BASF in the European vinyls sector. The synergies achieved in know-how and organization, the complementarities of product ranges as well as upstream integration have built up SolVin as a leader on the PVC and PVDC markets. The joint venture has operations in France, Germany, Spain and the Benelux countries and a total annual production capacity of 1.3 million tons of PVC, with nearly 2000 employees. Solvay owns 75% of SolVin and BASF, the remaining 25%.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.